Skip to main content
. 2020 Jun 4;8(1):e000266. doi: 10.1136/jitc-2019-000266

Figure 6.

Figure 6

In vivo effect of anti-Nectin4 mAb on tumors overexpressing Nectin4. (A–D) SCID-beige mice were subcutaneously implanted with 5×106 Raji cells either overexpressing Nectin4 (N4 oe) or empty vector (EV) either alone (A, B) or with 1×106 NK cells (C, D). (E, F) SCID-beige mice were subcutaneously implanted with 5×106 Raji cells overexpressing Nectin4 (N4 oe) and 1×106 NK cells. Mice were then treated with either anti-Nectin4 clone .05 mAb (clone .05) and or a control Ab. (A, C, E) Tumor growth was followed with standard caliper. Starting day of antibody treatment is marked by a black arrow. Tumor volumes were calculated by the formula: length×width2×0.5.21 (B, D, F) Tumors ware harvested and weighed on day 21 (B, D) or 27 (F) post tumor injection. For all murine experiments n=7. *p<0.05. NK, natural killer.